Rixathon indications. This will allow quick identification of new safety information. Rit...

Rixathon indications. This will allow quick identification of new safety information. Rituximab is a genetically engineered chimeric mouse/human monoclonal antibody representing a glycosylated immunoglobulin with human IgG1 constant regions and murine light-chain and heavy-chain variable region sequences. Feb 22, 2023 · Rixathon is typically administered by infusion, and the vial contains the concentrated liquid form of the medication. This means that Rixathon is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. Get all the details about Rixathon from MedicinesFAQ. Healthcare professionals are asked to report any suspected adverse reactions. A Patient Alert Card will be included in the carton. Its generic name is Rituximab. 4. 1 Therapeutic indications Non-Hodgkin’s lymphoma (NHL) Rixathon is indicated for the treatment of previously untreated adult patients with stage III-IV follicular lymphoma in combination with chemotherapy. 1 INDICATIONS AND USAGE 1. See ‘further information’ section for how to report adverse reactions. Rixathon slows down the damage to your joints caused by rheumatoid arthritis and improves your ability to do normal daily activities. The best responses to Rixathon are seen in those who have a positive blood test to rheumatoid factor (RF) and/or anti- Cyclic Citrullinated Peptide (anti-CCP). Important information about Rixathon® (rituximab) This medicinal product is subject to additional monitoring. Rixathon maintenance therapy is indicated for the treatment of adult follicular lymphoma patients responding to induction therapy. No Rixathon dose adjustments, other than by BSA, are required. Rixathon drug information: uses, indications, side effects, dosage. Rixathon (rituximab) is a monoclonal antibody that has revolutionized the treatment of certain types of cancer and autoimmune diseases. Rixathon 500mg/50ml Infusion manufactured by Sandoz GmbH. Rixathon is availble in United Arab Emirates. Only limited data are available for patients under 3 years of age. Rixathon maintenance therapy is indicated for the treatment of adult follicular lymphoma patients responding to induction therapy. The reference medicine for Rixathon is MabThera. For more information on biosimilar medicines, see here. 1 Non–Hodgkin’s Lymphoma (NHL) Rituxan (rituximab) is indicated for the treatment of patients with: Oct 6, 2025 · Rixathon monotherapy is indicated for treatment of adult patients with stage III-IV follicular lymphoma who are chemoresistant or are in their second or subsequent relapse after chemotherapy. Jan 7, 2025 · Learn about Rixathon uses, dosage, side effects, food interactions, and more. Rixathon monotherapy is Rixathon (rituximab) Patient Educational Leaflet - Important safety information for patients receiving Rixathon therapy The information provided in this booklet should be discussed with patients by their healthcare professional during Rixathon (rituximab) treatment. Rixathon 500 mg concentrate for solution for infusion Each 50 mL vial contains 500 mg of rituximab. Rixathon is a ‘biosimilar medicine’. Your doctor, pharmacist or nurse should give you a copy of the Rixathon® Patient Alert Card every time you have a Rixathon® infusion. Submitted Indication: Rixathon (also referred to as GP2013) is indicated in adults for the following indications: Non-Hodgkin’s lymphoma (NHL) Rixathon is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma (FL) in combination with chemotherapy. Jun 15, 2021 · Rixathon is indicated in adults for the following indications:Non-Hodgkin’s lymphoma (NHL)Rixathon is indicated for the treatment of previously untreated adult patients with stage III-IV follicular lymphoma in combination with chemotherapy. Compare prices for generic rixathon substitutes: Reditux, REDITUX RA, REDITUX-RA. Aug 14, 2025 · Rixathon 100 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Sandoz Limited Rituximab is indicated in adults for the following indications: Non-Hodgkin's lymphoma (NHL): Rituximab is indicated for the treatment of previously untreated adult patients with stage III-IV follicular lymphoma in combination with chemotherapy. Rixathon contains the active substance rituximab. Pneumocystis jirovecii pneumonia (PJP) prophylaxis is recommended for adult and paediatric patients with GPA/MPA and adult patients with PV during and following Rixathon treatment, as appropriate according to local clinical practice guidelines. The safety and efficacy of rituximab paediatric patients > 6 months to < 18 years of age has not been established in indications other than previously untreated advanced stage CD20 positive DLBCL/BL/BAL/BLL. blboa kbhpagn edsuzfkz wwkq lgktm agimlfy easmk bzfjh tbwo gcdzm